Mingxiang Ye, Yuemin Wang, Xinliang Ma, Jianming Pei
{"title":"罗格列酮不仅可以保护心肌免受2型糖尿病并发症的影响,还可以诱导心肌梗死:可能的机制?","authors":"Mingxiang Ye, Yuemin Wang, Xinliang Ma, Jianming Pei","doi":"10.1016/j.bihy.2009.03.004","DOIUrl":null,"url":null,"abstract":"<div><p>Rosiglitazone<span> is widely used to improve diabetes mellitus, but its adverse cardiovascular effect is recently recognized. The exact mechanism is still unknown. In this paper, we predict that rosiglitazone probably regulates the insulin gene expression, which cause complications in the long term use.</span></p></div>","PeriodicalId":87894,"journal":{"name":"Bioscience hypotheses","volume":"2 3","pages":"Pages 176-177"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bihy.2009.03.004","citationCount":"0","resultStr":"{\"title\":\"Rosiglitazone, not only potentially protects myocardium against complications of type 2 diabetes mellitus but also induces myocardium infarction: Possible mechanisms?\",\"authors\":\"Mingxiang Ye, Yuemin Wang, Xinliang Ma, Jianming Pei\",\"doi\":\"10.1016/j.bihy.2009.03.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Rosiglitazone<span> is widely used to improve diabetes mellitus, but its adverse cardiovascular effect is recently recognized. The exact mechanism is still unknown. In this paper, we predict that rosiglitazone probably regulates the insulin gene expression, which cause complications in the long term use.</span></p></div>\",\"PeriodicalId\":87894,\"journal\":{\"name\":\"Bioscience hypotheses\",\"volume\":\"2 3\",\"pages\":\"Pages 176-177\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.bihy.2009.03.004\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioscience hypotheses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756239209000470\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioscience hypotheses","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756239209000470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rosiglitazone, not only potentially protects myocardium against complications of type 2 diabetes mellitus but also induces myocardium infarction: Possible mechanisms?
Rosiglitazone is widely used to improve diabetes mellitus, but its adverse cardiovascular effect is recently recognized. The exact mechanism is still unknown. In this paper, we predict that rosiglitazone probably regulates the insulin gene expression, which cause complications in the long term use.